Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Talpaz

Showing results (11-20 of 263) with videos related to

Pageof 27
Sort By:
Cytokine & Growth Factor Reviews|August 21, 2007
The role of interferon-alpha in the treatment of chronic myeloid leukemiaLisa A Kujawski, Moshe Talpaz
The New England Journal of Medicine|September 4, 2009
Following the hedgehog to new cancer therapiesAndrzej A Dlugosz, Moshe Talpaz
Clinical Lymphoma & Myeloma|March 4, 2009
Efficacy of various doses and schedules of second-generation tyrosine kinase inhibitorsDale L Bixby, Moshe Talpaz
Clinical Lymphoma, Myeloma & Leukemia|April 17, 2019
SOHO State of the Art Updates and Next Questions: MyelofibrosisKristen Pettit, Srdan Verstovsek, Moshe Talpaz
Annals of Hematology|March 28, 2015
The interferon-alpha revival in CMLMoshe Talpaz, Jessica Mercer, Rüdiger Hehlmann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignanciesFarhad Ravandi, Moshe Talpaz, Zeev Estrov
British Journal of Haematology|October 3, 2002
STI-571 in chronic myelogenous leukaemiaAnne S Tsao, Hagop Kantarijian, Moshe Talpaz
Oncology (Williston Park, N.Y.)|March 18, 1999
Chronic myelogenous leukemia: update on biology and treatmentStefan Faderl, Hagop M Kantarjian, Moshe Talpaz
Cancer Research|February 7, 2002
Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53Laura S Angelo, Moshe Talpaz, Razelle Kurzrock
The New England Journal of Medicine|February 7, 2014
Ponatinib in Philadelphia chromosome-positive leukemiasJorge E Cortes, Moshe Talpaz, Hagop Kantarjian
Pageof 27

Showing results (11-20 of 263) with videos related to

Sort By:
Pageof 27
Cytokine & Growth Factor Reviews|August 21, 2007
The role of interferon-alpha in the treatment of chronic myeloid leukemiaLisa A Kujawski, Moshe Talpaz
The New England Journal of Medicine|September 4, 2009
Following the hedgehog to new cancer therapiesAndrzej A Dlugosz, Moshe Talpaz
Clinical Lymphoma & Myeloma|March 4, 2009
Efficacy of various doses and schedules of second-generation tyrosine kinase inhibitorsDale L Bixby, Moshe Talpaz
Clinical Lymphoma, Myeloma & Leukemia|April 17, 2019
SOHO State of the Art Updates and Next Questions: MyelofibrosisKristen Pettit, Srdan Verstovsek, Moshe Talpaz
Annals of Hematology|March 28, 2015
The interferon-alpha revival in CMLMoshe Talpaz, Jessica Mercer, Rüdiger Hehlmann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignanciesFarhad Ravandi, Moshe Talpaz, Zeev Estrov
British Journal of Haematology|October 3, 2002
STI-571 in chronic myelogenous leukaemiaAnne S Tsao, Hagop Kantarijian, Moshe Talpaz
Oncology (Williston Park, N.Y.)|March 18, 1999
Chronic myelogenous leukemia: update on biology and treatmentStefan Faderl, Hagop M Kantarjian, Moshe Talpaz
Cancer Research|February 7, 2002
Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53Laura S Angelo, Moshe Talpaz, Razelle Kurzrock
The New England Journal of Medicine|February 7, 2014
Ponatinib in Philadelphia chromosome-positive leukemiasJorge E Cortes, Moshe Talpaz, Hagop Kantarjian
Pageof 27